$0.118
+0.012 (+9.81%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BTAI por análisis de gráficos similares
Alphio's BTAI stock price prediction model matches the current BioXcel Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.12 (-1.61%). The 1-week path is $0.12 (-2.02%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BioXcel Therapeutics Inc?
Given the current price of $0.1814 and the recent bankruptcy filing, BioXcel Therapeutics is not a good buy right now. The stock has plummeted 77.43% in the last five days and has a very low RSI of 10.284, indicating extreme oversold conditions. The company's financial health is concerning, with a net income loss of $14.7 million in Q2 2026 and a gross margin of only 87.91%. The main risk is the ongoing bankruptcy proceedings, which could further dilute shareholder value.
BTAI cerró en $0.12 el Thursday, tras subir +9.81%
BioXcel Therapeutics Inc (BTAI) last closed at $0.1175, gaining +9.81%. These facts feed the 1-day and 1-week BTAI price prediction above.
Consenso de analistas
BioXcel Therapeutics Inc (BTAI): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de BioXcel Therapeutics Inc (BTAI) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BTAI, ordenadas por similitud.
Análisis de estacionalidad de BTAI
Historically the probability of a positive September return for BTAI is 0.00%. January offers the highest probability of a positive month at 39.34%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BTAI
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.66 | $0.77 | $0.85 | +554.43% |
| Oct 2026 | $0.57 | $0.72 | $0.74 | +510.13% |
| Nov 2026 | $0.92 | $0.94 | $0.95 | +696.82% |
| Dec 2026 | $0.70 | $0.86 | $0.94 | +632.28% |
En 2026, se proyecta que BioXcel Therapeutics Inc (BTAI) oscile entre $0.57 y $0.95.
Previsión mensual de BioXcel Therapeutics Inc para 2026
En Sep de 2026, se proyecta que BioXcel Therapeutics Inc promedie $0.77, con un mínimo de $0.66 y un máximo de $0.85.
En Oct de 2026, se proyecta que BioXcel Therapeutics Inc promedie $0.72, con un mínimo de $0.57 y un máximo de $0.74.
En Nov de 2026, se proyecta que BioXcel Therapeutics Inc promedie $0.94, con un mínimo de $0.92 y un máximo de $0.95.
En Dec de 2026, se proyecta que BioXcel Therapeutics Inc promedie $0.86, con un mínimo de $0.70 y un máximo de $0.94.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.